edigene.com
Get leads like Edigene — and thousands more
Build targeted lists by tech stack, traffic, and more
EdiGene: China's Precision Gene Editing Powerhouse
A $179M-backed biotech turning genetic code into cures for cancer and hereditary diseases
In the high-stakes arena of gene editing, EdiGene isn't just editing DNA—it's rewriting the playbook for how biotech translates scientific breakthroughs into tangible therapies. While most startups struggle with the 'valley of death' between research and revenue, this Beijing-based company has secured $179.7M in funding to bridge that gap with proprietary platforms that dissect functional genomic data at scale.
"EdiGene isn't chasing headlines—it's building the infrastructure to decode biology's most stubborn problems."
The Precision Medicine Playbook
EdiGene's core thesis is deceptively simple: gene editing isn't just about CRISPR scissors—it's about high-throughput screening that turns messy biological data into actionable therapeutic insights. Their proprietary platform doesn't just edit genes; it systematically maps functional consequences across disease pathways, creating a data moat that generic gene editing tools can't replicate. This is why they're targeting hereditary diseases and cancers where traditional drug discovery fails.
The Funding-to-Execution Gap
With $179.7M in funding but only $2.7M in revenue, EdiGene exemplifies the capital-intensive nature of deep biotech. The 66:1 funding-to-revenue ratio signals a pre-commercial phase focused on platform validation rather than immediate monetization. This isn't a red flag—it's the reality of gene therapy development where clinical trials alone can burn $100M+. The 70-person team suggests lean operations despite substantial capital, likely prioritizing R&D over commercial scaling.
What's particularly telling is their traffic profile: 935 monthly visits with 44% direct traffic. This isn't a consumer-facing biotech chasing vanity metrics—it's a B2B/B2G operation where decision-makers manually type in the domain. The top keyword '袁鹏飞' (founder Yuan Pengfei) commanding 280 monthly searches reveals a founder-led brand where technical reputation drives inbound interest more than SEO-optimized content.
- Proprietary platform enables high-throughput genomic screening beyond standard CRISPR tools
- Dual focus on therapeutic development (cancer, genetic diseases) and drug discovery services
- Leadership team combines deep academic credentials with operational experience
- Strategic funding position allows multi-year R&D runway without premature revenue pressure
EdiGene's Real Bet: Platform Depth Over Geographic Breadth
While Western gene editing companies chase global expansion, EdiGene is doubling down on China's massive patient population and streamlined regulatory environment. Their $179M war chest isn't for marketing—it's for proving their platform can deliver therapies where others have failed. For investors, this is a patient capital play with asymmetric upside: if they crack even one major hereditary disease pathway, the revenue multiple expansion could be staggering.
What tech stack does Edigene use?
How much traffic does Edigene get?
Traffic & Engagement
Traffic Sources
Where is Edigene's audience located?
What keywords does Edigene rank for?
3 keywordsHow is Edigene's SEO?
Meta Tags
博雅辑因 | 辑生命之密码 解世间之顽疾
EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。
What is Edigene's revenue?
Who works at Edigene?
Loading leads...
What do customers think of Edigene?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Edigene
What is Edigene's Revenue?
What does Edigene do?
How fast is Edigene growing?
What technologies does Edigene use?
Who are Edigene's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Edigene?
What are Edigene's key pages?
Export edigene.com Data
Download the complete tech stack, analytics, leads, and company data for edigene.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About edigene.com
EdiGene是一家生物技术公司，其使命是将前沿的基因组编辑技术转化为治疗遗传病和癌症的新疗法，并将其转化为创新的解决方案，以推进药物发现。我们利用我们的专有平台来开发针对一系列疾病的基因编辑疗法，并进行高通量的基因组筛选，以便能够在生物学环境中剖析功能性大数据。
Company Overview
edigene.com Key Pages
Contact edigene.com
Email Addresses
Phone Numbers
Technology Stack
edigene.com uses 8 technologies across their website including HSTS, Ruby on Rails, Zendesk, and more.
Security
HSTS
Backend Frameworks
Ruby on Rails
Customer Support
Zendesk
CSS Frameworks
Bootstrap, Tailwind CSS
JavaScript Libraries
Swiper, Prism, jQuery
Traffic & Audience
edigene.com receives approximately 935 monthly visitors. The website has a bounce rate of 37% with visitors viewing an average of 2.1 pages per visit. Users spend an average of 0:52 on the site.
The majority of edigene.com's traffic comes from .
Frequently Asked Questions
What is edigene.com?
What technologies does edigene.com use?
How do I contact edigene.com?
How popular is edigene.com?
Related Searches
This page provides publicly available information about edigene.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit edigene.com directly at https://edigene.com.